Sex-specific association of the SPTY2D1 rs7934205 polymorphism and serum lipid levels

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 1, 2015, Pages 665-681

  Guo, Tao ^a   Yin, Rui Xing ^a   Chen, Xia ^a   Bin, Yuan ^a   Nie, Rong Jun ^a   Li, Hui ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Environmental factors; Lipids; Sex specific association; Single nucleotide polymorphism; SPTY2D1

Indexed keywords

CHAPERONE; LIPID; SPT2 PROTEIN, HUMAN;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CARDIOVASCULAR DISEASE; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEXUAL DEVELOPMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HISTONE CHAPERONES; HUMANS; LIPIDS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX CHARACTERISTICS;

EID: 84923114127     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Lv J, Liu M, Jiang Y and Li LM. Prevention and control of major non-communicable diseases in China from 1990 to 2009: results of a two-round Delphi survey. Glob Health Action 2013; 6: 20004.
2. Yang ZJ, Liu J, Ge JP, Chen L, Zhao ZG, Yang WY; China National Diabetes and Metabolic Disorders Study Group. Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study. Euro Heart J 2012; 33: 213-220.
3. Ginsberg HN and Stalenhoef AF. The metabolic syndrome targeting dyslipidaemia to reduce coronary risk. J Cardiovasc Risk 2003; 10: 121-128.
4. Zhang R, Zhao L, Liang L, Xie G and Wu Y. Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy. Lipids Health Dis 2012; 11: 59.
5. Randomised trial of cholesterol lowering. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
6. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-1278.
7. Mittendorfer B. Sexual dimorphism in human lipid metabolism. J Nutr 2005; 135: 681-686.
8. Wang X, Magkos F and Mittendorfer B. Sex differences in lipid and lipoproteinmetabolism: it's not just about sex hormones. J Clin Endocrinol Metab 2011; 96: 885-893.
9. Ansell BJ, Fonarow GC, Maki KC, Dicklin MR, Bell M, Davidson MH; NEPTUNE II Steering Committee. Reduced treatment success in lipid management among women with coronary heart disease or risk equivalents: results of a national survey. Am Heart J 2006; 152: 976-981.
10. Santos RD, Waters DD, Tarasenko L, Messig M, Jukema JW, Ferrières J, Verdejo J, Chiang CW; L-TAP 2 Investigators. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Asse-ssment Project (L-TAP) 2. Am Heart J 2009; 158: 860-866.
11. Dallongevillle J, De Bacquer D, Heidrich J, De Backer G, Prugger C, Kotseva K, Montaye M, Amouyel P; EUROASPIRE Study Group. Gender differences in the implementation of cardiovascular prevention measures after an acute coronary event. Heart 2010; 96: 1744-1749.
12. Pearson TA, Laurora I, Chu H and Kafonek S. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 2000; 160: 459-467.
13. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol 2000; 86: 943-949.
14. Meagher EA. Addressing cardiovascular disease in women: focus on dyslipidemia. J Am Board Fam Pract 2004; 17: 424-437.
15. Teo YY and Sim X. Patterns of linkage disequilibrium in different populations implications and opportunities for lipid-associated loci identified from genome-wide association studies. Curr Opin Lipidol 2010; 21: 104-115.
16. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ, Johansen CT, Fouchier SW, Isaacs A, Peloso GM, Barbalic M, Ricketts SL, Bis JC, Aulchenko YS, Thorleifsson G, Feitosa MF, Chambers J, Orho-Melander M, Melander O, Johnson T, Li X, Guo X, Li M, Shin Cho Y, Jin Go M, Jin Kim Y, Lee JY, Park T, Kim K, Sim X, Twee-Hee Ong R, Croteau-Chonka DC, Lange LA, Smith JD, Song K, Hua Zhao J, Yuan X, Luan J, Lamina C, Ziegler A, Zhang W, Zee RY, Wright AF, Witteman JC, Wilson JF, Willemsen G, Wichmann HE, Whitfield JB, Waterworth DM, Wareham NJ, Waeber G, Vollenweider P, Voight BF, Vitart V, Uitterlinden AG, Uda M, Tuomilehto J, Thompson JR, Tanaka T, Surakka I, Stringham HM, Spector TD, Soranzo N, Smit JH, Sinisalo J, Silander K, Sijbrands EJ, Scuteri A, Scott J, Schlessinger D, Sanna S, Salomaa V, Saharinen J, Sabatti C, Ruokonen A, Rudan I, Rose LM, Roberts R, Rieder M, Psaty BM, Pramstaller PP, Pichler I, Perola M, Penninx BW, Pedersen NL, Pattaro C, Parker AN, Pare G, Oostra BA, O'Donnell CJ, Nieminen MS, Nickerson DA, Montgomery GW, Meitinger T, McPherson R, McCarthy MI, McArdle W, Masson D, Martin NG, Marroni F, Mangino M, Magnusson PK, Lucas G, Luben R, Loos RJ, Lokki ML, Lettre G, Langenberg C, Launer LJ, Lakatta EG, Laaksonen R, Kyvik KO, Kronenberg F, König IR, Khaw KT, Kaprio J, Kaplan LM, Johansson A, Jarvelin MR, Janssens AC, Ingelsson E, Igl W, Kees Hovingh G, Hottenga JJ, Hofman A, Hicks AA, Hengstenberg C, Heid IM, Hayward C, Havulinna AS, Hastie ND, Harris TB, Haritunians T, Hall AS, Gyllensten U, Guiducci C, Groop LC, Gonzalez E, Gieger C, Freimer NB, Ferrucci L, Erdmann J, Elliott P, Ejebe KG, Döring A, Dominiczak AF, Demissie S, Deloukas P, de Geus EJ, de Faire U, Crawford G, Collins FS, Chen YD, Caulfield MJ, Campbell H, Burtt NP, Bonnycastle LL, Boomsma DI, Boekholdt SM, Bergman RN, Barroso I, Bandinelli S, Ballantyne CM, Assimes TL, Quertermous T, Altshuler D, Seielstad M, Wong TY, Tai ES, Feranil AB, Kuzawa CW, Adair LS, Taylor HA Jr, Borecki IB, Gabriel SB, Wilson JG, Holm H, Thorsteinsdottir U, Gudnason V, Krauss RM, Mohlke KL, Ordovas JM, Munroe PB, Kooner JS, Tall AR, Hegele RA, Kastelein JJ, Schadt EE, Rotter JI, Boerwinkle E, Strachan DP, Mooser V, Stefansson K, Reilly MP, Samani NJ, Schunkert H, Cupples LA, Sandhu MS, Ridker PM, Rader DJ, van Duijn CM, Peltonen L, Abecasis GR, Boehnke M and Kathiresan S. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010; 466: 707-713.
17. Jeemon P, Pettigrew K, Sainsbury C, Prabhakaran D, Padmanabhan S. Implications of discoveries from genome-wide association studies in current cardiovascular practice. World J Cardiol 2011; 3: 230-247.
18. Asselbergs FW, Guo Y, van Iperen EP, Sivapalaratnam S, Tragante V, Lanktree MB, Lange LA, Almoguera B, Appelman YE, Barnard J, Baumert J, Beitelshees AL, Bhangale TR, Chen YD, Gaunt TR, Gong Y, Hopewell JC, Johnson T, Kleber ME, Langaee TY, Li M, Li YR, Liu K, McDonough CW, Meijs MF, Middelberg RP, Musunuru K, Nelson CP, O'Connell JR, Padmanabhan S, Pankow JS, Pankratz N, Rafelt S, Rajagopalan R, Romaine SP, Schork NJ, Shaffer J, Shen H, Smith EN, Tischfield SE, van der Most PJ, van Vliet-Ostaptchouk JV, Verweij N, Volcik KA, Zhang L, Bailey KR, Bailey KM, Bauer F, Boer JM, Braund PS, Burt A, Burton PR, Buxbaum SG, Chen W, Cooper-Dehoff RM, Cupples LA, deJong JS, Delles C, Duggan D, Fornage M, Furlong CE, Glazer N, Gums JG, Hastie C, Holmes MV, Illig T, Kirkland SA, Kivimaki M, Klein R, Klein BE, Kooperberg C, Kottke-Marchant K, Kumari M, LaCroix AZ, Mallela L, Murugesan G, Ordovas J, Ouwehand WH, Post WS, Saxena R, Scharnagl H, Schreiner PJ, Shah T, Shields DC, Shimbo D, Srinivasan SR, Stolk RP, Swerdlow DI, Taylor HA Jr, Topol EJ, Toskala E, van Pelt JL, van Setten J, Yusuf S, Whittaker JC, Zwinderman AH; LifeLines Cohort Study, Anand SS, Balmforth AJ, Berenson GS, Bezzina CR, Boehm BO, Boerwinkle E, Casas JP, Caulfield MJ, Clarke R, Connell JM, Cruickshanks KJ, Davidson KW, Day IN, de Bakker PI, Doevendans PA, Dominiczak AF, Hall AS, Hartman CA, Hengstenberg C, Hillege HL, Hofker MH, Humphries SE, Jarvik GP, Johnson JA, Kaess BM, Kathiresan S, Koenig W, Lawlor DA, März W, Melander O, Mitchell BD, Montgomery GW, Munroe PB, Murray SS, Newhouse SJ, Onland-Moret NC, Poulter N, Psaty B, Redline S, Rich SS, Rotter JI, Schunkert H, Sever P, Shuldiner AR, Silverstein RL, Stanton A, Thorand B, Trip MD, Tsai MY, van der Harst P, van der Schoot E, van der Schouw YT, Verschuren WM, Watkins H, Wilde AA, Wolffenbuttel BH, Whitfield JB, Hovingh GK, Ballantyne CM, Wijmenga C, Reilly MP, Martin NG, Wilson JG, Rader DJ, Samani NJ, Reiner AP, Hegele RA, Kastelein JJ, Hingorani AD, Talmud PJ, Hakonarson H, Elbers CC, Keating BJ and Drenos F. Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet 2012; 91: 823-838.
19. Xu L, Deng QY, Li SF, Zhou LN, Gong JC and Wei BY. Genetic analysis of Mulao nationality using 15 short tandem repeats. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2008; 25: 96-100.
20. Guo T, Yin RX, Lin QZ, Wu J, Shen SW, Sun JQ, Shi GY, Wu JZ, Li H and Wang YM. Polymorphism of rs873308 near the transmembrane protein 57 gene is associated with serum lipid levels. Biosci Rep 2014; 34: e00095.
21. Lin QZ, Yin RX, Guo T, Wu J, Sun JQ, Shen SW, Shi GY, Wu JZ, Liu CW and Pan SL. Association of the ST3GAL4 rs11220462 polymorphism and serum lipid levels in the Mulao and Han populations. Lipids Health Dis 2014; 13: 123.
22. Aung LH, Yin RX, Wu DF, Wang W, Wu JZ and Liu CW. Sex-specific Association of the Zinc Finger Protein 259 rs2075290 Polymorphism and Serum Lipid Levels. Int J Med Sci 2014; 11: 471-478.
23. Ruixing Y, Qiming F, Dezhai Y, Shuquan L, Weixiong L, Shangling P, Hai W, Yongzhong Y, Feng H and Shuming Q. Comparison of demography, diet, lifestyle, and serum lipid levels between the Guangxi Bai Ku Yao and Han populations. J Lipid Res 2007; 48: 2673-2681.
24. Ruixing Y, Dezhai Y, Shuquan L, Yuming C, Hanjun Y, Qiming F, Shangling P, Weixiong L, Jing T and Yiyang L. Hyperlipidaemia and its risk factors in the Guangxi Bai Ku Yao and Han populations. Public Health Nutr 2009; 12: 816-824.
25. Aung LH, Yin RX, Wu JZ, Wu DF, Wang W and Li H. Association between the MLX interacting protein-like, BUD13 homolog and zinc finger protein 259 gene polymorphisms and serum lipid levels. Sci Rep 2014; 4: 5565.
26. Aung LH, Yin RX, Wu DF, Wang W, Liu CW and Pan SL. Association of the variants in the BUD13-ZNF259 genes and the risk of hyperlipidaemia. J Cell Mol Med 2014; 18: 1417-1428.
27. Bermudez OI, Velez-Carrasco W, Schaefer EJ and Tucker KL. Dietary and plasma lipid, lipoprotein, and apolipoprotein profiles among elderly Hispanics and non-Hispanics and their association with diabetes. Am J Clin Nutr 2002; 76: 1214-1221.
28. Garcia-Palmieri MR, Tillotson J, Cordero E, Costas R Jr, Sorlie P, Gordon T, Kannel WB and Colon AA. Nutrient intake and serum lipids in urban and rural Puerto Rican men. Am J Clin Nutr 1977; 30: 2092-2100.
29. Sola R, Fito M, Estruch R, Salas-Salvadó J, Corella D, de La Torre R, Muñoz MA, López-Sabater Mdel C, Martínez-González MA, Arós F, Ruiz-Gutierrez V, Fiol M, Casals E, Wärnberg J, Buil-Cosiales P, Ros E, Konstantinidou V, Lapetra J, Serra-Majem L and Covas MI. Effect of a traditional Mediterranean diet on apolipoproteins B, A-I, and their ratio a randomized, controlled trial. Atherosclerosis 2011; 218: 174-180.
30. Valente EA, Sheehy ME, Avila JJ, Gutierres JA, Delmonico MJ and Lofgren IE. The effect of the addition of resistance training to a dietary education intervention on apolipoproteins and diet quality in overweight and obese older adults. Clin Interv Aging 2011; 6: 235-241.
31. Watts GF, Jackson P, Burke V and Lewis B. Dietary fatty acids and progression of coronary artery disease in men. Am J Clin Nutr 1996; 64: 202-209.
32. Grundy SM and Denke MA. Dietary influences on serum lipids and lipoproteins. J Lipid Res 1990; 31: 1149-1172.
33. Arca M, Vega GL and Grundy SM. Hyper-cholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin. JAMA 1994; 271: 453-459.
34. Karjalainen A, Heikkinen J, Savolainen MJ, Bäckström AC and Kesäniemi YA. Mechanisms regulating LDL metabolism in subjects on peroral and transdermal estrogen replacement therapy. Arterioscler Thromb Vasc Biol 2000; 20: 1101-1106.
35. Gouva L and Tsatsoulis A. The role of estrogens in cardiovascular disease in the aftermath of clinical trials. Hormones 2004; 3: 171-183.
36. Weiss TW, Seljeflot IS, Hjerkinn EM and Arnesen H. Adipose tissue pro-inflammatory gene expression is associated with cardiovascular disease. Int J Clin Pract 2011; 65: 939-944.
37. Von Deneen KM, Wei Q, Tian J and Liu Y. Obesity in China: What are the Causes? Curr Pharm Des 2011; 17: 1132-1139.
38. Jin L, Huang Y, Bi Y, Zhao L, Xu M, Xu Y, Chen Y, Gu L, Dai M, Wu Y, Hou J, Li X and Ning G. Association between alcohol consumption and metabolic syndrome in 19,215 middle-aged and elderly Chinese. Diabetes Res Clin Pract 2011; 92: 386-392.
39. Yu-Poth S, Zhao G, Etherton T, Naglak M, Jonnalagadda S and Kris-Etherton PM. Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 1999; 69: 632-646.
40. Rimm EB, Williams P, Fosher K, Criqui M and Stampfer MJ. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ 1999; 319: 1523-1528.
41. Yin RX, Wu DF, Miao L, Htet Aung LH, Cao XL, Yan TT, Long XJ, Liu WY, Zhang L and Li M. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits. Biofactors 2013; 39: 315-325.
42. Yin RX, Wu DF, Miao L, Aung LH, Cao XL, Yan TT, Long XJ, Liu WY, Zhang L and Li M. Several genetic polymorphisms interact with overweight/obesity to influence serum lipid levels. Car-diovasc Diabetol 2012; 11: 123.